Remote Ischemic Conditioning

(RIC)


Brief episodes of repetitive ischemia/reperfusion (e.g. 4 cycles of 5 minutes ischemia/5 minutes reperfusion) applied to a limb induce REMOTE protection of other organs (e.g. the heart) against potentially lethal ischemic/reperfusion injury.




The autoRIC™ Device

CE Mark approved for EU
Health Canada Class III License Approval
[For Regulated Research Use Only in US]


The autoRIC™ device is a new, portable, automated device that provides 'point of care' delivery of remote ischemic conditioning that does not impede use of other standard of care; while remaining simple, consistent, and time-efficient to administer.


Company News

CellAegis Devices Announces Second Clinical Program to Use the Company's Noninvasive autoRIC™ Device for Chronic Remote Ischemic Conditioning (CRIC) following Acute Myocardial Infarction (AMI)
May 2, 2013 - Toronto, ON...Read More +

CellAegis Devices Announces Clinical Program to Use the Company's Noninvasive autoRIC™ Device for Chronic Remote Ischemic Conditioning (CRIC) following Acute Myocardial Infarction (AMI)
February 27, 2013 - Toronto, ON...Read More +

CellAegis Devices Announces Initiation of Clinical Testing of Remote Ischemic Conditioning (RIC) Using the autoRIC™ Device for Patients Undergoing Partial Nephrectomy
November 12, 2012 - Toronto, ON...Read More +

CellAegis Devices Announces First Clinical Program to Use the Company's autoRIC™ Device for Remote Ischemic Conditioning during Myocardial Infarction
August 27, 2012 - Toronto, ON...Read More +

CellAegis Devices Expands Scientific Advisory Board with the Appointment of Sidney Levitsky, M.D.
August 9, 2012 - Toronto, ON...Read More +

CellAegis Devices Receives CE Mark for autoRIC™ Device in the European Union
July 18, 2012 - Toronto, ON...Read More +

CellAegis passes ISO 13485:2003/CMDCAS,
MDD Annex II certification

RIC Clinical Research Updates

Ischemic Preconditioning for Prevention of Contrast Medium-Induced Nephropathy
Fikret Er, Amir M. Nia... Read More +

RIC Before Hospital Admission... A Randomised Trial:
Hans Erik Bøtker, Rajesh Kharbanda... Read More +

The Therapeutic Potential of Ischemic Conditioning:
Hausenloy & Yellon... Read More +

Translation of RIPC Into Clinical Practice:
Rajesh K. Kharbanda, Torsten Toftgard Nielsen,
Andrew N. Redington... Read More +